Seidel, J. A., Otsuka, A., & Kabashima, K. (2018). Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations. Frontiers in oncology, 8, 86. https://doi.org/10.3389/fonc.2018.00086
Chicago Style (17th ed.) CitationSeidel, Judith A., Atsushi Otsuka, and Kenji Kabashima. "Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations." Frontiers in Oncology 8 (2018): 86. https://doi.org/10.3389/fonc.2018.00086.
MLA (9th ed.) CitationSeidel, Judith A., et al. "Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations." Frontiers in Oncology, vol. 8, 2018, p. 86, https://doi.org/10.3389/fonc.2018.00086.
Warning: These citations may not always be 100% accurate.